A detailed history of Bank Of New Hampshire transactions in Geron Corp stock. As of the latest transaction made, Bank Of New Hampshire holds 2,000 shares of GERN stock, worth $5,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 1,000 100.0%
Holding current value
$5,120
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 07, 2025

BUY
$3.3 - $4.44 $3,300 - $4,440
1,000 Added 100.0%
2,000 $7,000
Q2 2024

Jul 01, 2024

BUY
$3.1 - $5.09 $3,100 - $5,090
1,000 New
1,000 $4,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $967M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.